Biochemicals and Reagents

A synthetic peptide for use as a blocking control in assays to test for specificity of EXOC3 antibody, catalog no. 70R-2856

A synthetic peptide for use as a blocking control in assays to test for specificity of SNX5 antibody, catalog no. 70R-5748

A synthetic peptide for use as a blocking control in assays to test for specificity of ACSL4 antibody, catalog no. 70R-7155

The CCL2 antibody is a monoclonal antibody that targets the chemokine CCL2, also known as monocyte chemoattractant protein-1 (MCP-1). It is used in Life Sciences research to study the role of CCL2 in various physiological and pathological processes. This antibody specifically binds to CCL2 and can be used for applications such as immunohistochemistry, flow cytometry, and ELISA. The CCL2 antibody has been shown to inhibit the interaction between CCL2 and its receptor, thereby blocking the recruitment of monocytes and other immune cells to inflammatory sites. It is also nephrotoxic in nature, which means it can cause damage to kidney cells. Additionally, polyclonal antibodies derived from human serum or monoclonal antibodies like adalimumab can be used as alternatives to the CCL2 antibody for specific research purposes.

JNJ-42153605 is a novel allosteric modulator of the NMDA receptor. It is an agonist at the MGLUR2 receptor and has been shown to have a long-term treatment effect in animal models. JNJ-42153605 has also been shown to be effective in clinical trials for the treatment of patients with major depressive disorder and schizophrenia. The onset latency of this drug is less than one hour and its effects last up to 24 hours. This drug binds to glutamate receptors, which are ionotropic receptors that mediate fast synaptic transmission. JNJ-42153605 acts as an allosteric modulator by binding to a site that is different from the agonist binding site, but near it. The binding of JNJ-42153605 at this site increases the affinity of glutamate for its receptor, leading to increased uptake and activation of ion channels. This leads to excitatory postsynaptic potentials (EPSPs) and

A synthetic peptide for use as a blocking control in assays to test for specificity of Vamp1 antibody, catalog no. 70R-9793

A synthetic peptide for use as a blocking control in assays to test for specificity of RAB18 antibody, catalog no. 70R-5796

A synthetic peptide for use as a blocking control in assays to test for specificity of COMMD1 antibody, catalog no. 70R-10355

PYGO1 antibody was raised in rabbit using the middle region of PYGO1 as the immunogen

A synthetic peptide for use as a blocking control in assays to test for specificity of NSMCE1 antibody, catalog no. 70R-2769

A synthetic peptide for use as a blocking control in assays to test for specificity of TMCC3 antibody, catalog no. 70R-6900

A synthetic peptide for use as a blocking control in assays to test for specificity of SLCO3A1 antibody, catalog no. 70R-6586

JMJD5 antibody was raised in rabbit using the middle region of JMJD5 as the immunogen

A synthetic peptide for use as a blocking control in assays to test for specificity of HERC5 antibody, catalog no. 70R-5524

Purified Horse IgG (Fab'2) FITC conjugate

IL10 antibody is a medicament that belongs to the class of antibodies. It is a protein complex that specifically targets and binds to IL10, a cytokine involved in immune regulation. IL10 antibody can be used as a therapeutic agent for various diseases characterized by excessive IL10 activity, such as autoimmune disorders and inflammatory conditions. This monoclonal antibody has been extensively studied in the field of Life Sciences and has shown promising results in preclinical and clinical trials. It has the ability to neutralize the effects of IL10, thereby reducing its immunosuppressive and anti-inflammatory properties. IL10 antibody is also being investigated for its potential antiviral activity and its ability to enhance the effectiveness of multidrug therapies.

A synthetic peptide for use as a blocking control in assays to test for specificity of MAT2B antibody, catalog no. 70R-3455

A synthetic peptide for use as a blocking control in assays to test for specificity of NKX6-3 antibody, catalog no. 70R-8429

A synthetic peptide for use as a blocking control in assays to test for specificity of TIGD3 antibody, catalog no. 70R-2971

A synthetic peptide for use as a blocking control in assays to test for specificity of ABCD4 antibody, catalog no. 70R-1784

ELISA kit for the detection of ANA in the research laboratory

TGF beta 1 antibody was raised in mouse using highly pure recombinant human TGF-beta1 as the immunogen.

Purified Polyclonal THRB antibody

A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM144 antibody, catalog no. 70R-6575

MMACHC antibody was raised in rabbit using the C terminal of MMACHC as the immunogen

Arabidopsis Thaliana Plant Lysate

A synthetic peptide for use as a blocking control in assays to test for specificity of SPINK6 antibody, catalog no. 70R-9366

Goat anti-human lambda chain was raised in goat using human lambda light chain as the immunogen.

A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM49 antibody, catalog no. 70R-2803

Rabbit polyclonal ZNF225 antibody

1-282 amino acids: MSGADRSPNA GAAPDSAPGQ AAVASAYQRF EPRAYLRNNY APPRGDLCNP NGVGPWKLRC LAQTFATGEV SGRTLIDIGS GPTVYQLLSA CSHFEDITMT DFLEVNRQEL GRWLQEEPGA FNWSMYSQHA CLIEGKGECW QDKERQLRAR VKRVLPIDVH QPQPLGAGSP APLPADALVS AFCLEAVSPD LASFQRALDH ITTLLRPGGH LLLIGALEES WYLAGEARLT VVPVSEEEVR EALVRSGYKV RDLRTYIMPA HLQTGVDDVK GVFFAWAQKV GL

A synthetic peptide for use as a blocking control in assays to test for specificity of DHRSX antibody, catalog no. 70R-7875

GALE antibody was raised in Rabbit using Human GALE as the immunogen

A synthetic peptide for use as a blocking control in assays to test for specificity of FAM118A antibody, catalog no. 70R-4554

Bin1 antibody was raised in rabbit using the N terminal of Bin1 as the immunogen

ELISA kit for the detection of Rheumatoid Factor IgM in the research laboratory

Rabbit polyclonal PIN1 antibody (Ser16)

The FER antibody is a powerful tool used in life sciences research for the detection and analysis of messenger RNA (mRNA). It belongs to the category of antibodies, specifically polyclonal antibodies. This cytotoxic antibody is designed to target specific proteins, particularly glycoproteins, and can be used for various applications such as protein immobilization and chromatographic purification. The FER antibody has the unique ability to neutralize binding proteins, including growth factors like hepatocyte growth factor and angiopoietin-like 3 (ANGPTL3). Its high specificity and sensitivity make it an invaluable asset in the field of molecular biology and biomedical research.

A synthetic peptide for use as a blocking control in assays to test for specificity of SMPD1 antibody, catalog no. 70R-7120

A synthetic peptide for use as a blocking control in assays to test for specificity of ABCF2 antibody, catalog no. 70R-5703

AKR1C1 antibody was raised in mouse using recombinant human AKR1C1 (1-323aa) purified from E. coli as the immunogen.

o-Hydroxyethyl metronidazole is an antibiotic that is used to treat infections caused by bacteria. It is a prodrug that undergoes hydrolysis in vivo to form the active compound, metronidazole. Metronidazole binds to bacterial DNA and inhibits the synthesis of proteins, leading to death of the cell. o-Hydroxyethyl metronidazole can be used for the treatment of anaerobic infections and infections caused by aerobic bacteria. The drug has been shown to be effective in treating infections of the colon, but not those of the urinary tract or respiratory tract.

The HIPK2 antibody is a highly specialized tool used in Life Sciences research. It is a Polyclonal Antibody that is designed for the ultrasensitive detection and neutralization of clostridial neurotoxins. The antibody can be immobilized on a carbon electrode, allowing for electrochemical impedance spectroscopy to be performed. This technique enables researchers to accurately measure the presence and activity of the toxins in various samples.

ACTA1 antibody was raised in rabbit using the N terminal of ACTA1 as the immunogen

A synthetic peptide for use as a blocking control in assays to test for specificity of EIF2C4 antibody, catalog no. 70R-3041

The HSF1 antibody is a powerful tool in the field of Life Sciences. It is a monoclonal antibody that specifically targets and neutralizes arginase, an enzyme involved in various cellular processes. This antibody has been extensively studied and proven to be highly effective in blocking the activity of arginase, allowing researchers to investigate its role in different biological systems.

Purified Polyclonal NAA15 antibody

Catalogue peptide; min. 95% purity

Catalogue peptide; min. 95% purity